Sysmex

Skip Navigation

SearchMenu

About Sysmex

Press Release

▼ Old News

2018rss

Nov. 13, 2018 Products & Solution Products & Solution
Sysmex Launches Single Molecule Fluorescence Microscope HM-1000 for Research Use
-Supporting R&D Related to New Therapeutic Drugs and Diagnostic Methods with a Super-Resolution Fluorescence Microscope Having High Spatial Resolution-
Nov. 08, 2018 Research & Development Research & Development
Sysmex Wins Awards in 2018 Kinki Local Commendations for Innovations
Nov. 07, 2018 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2019 (PDF:579KB)
Nov. 07, 2018 Investor Relations Investor Relations
Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2018, and Revision of Full-Year Financial Forecasts (PDF:62KB)
Oct. 22, 2018 Research & Development Research & Development
Strengthening Our Global R&D Structure to Foster Early-Stage Innovation
Oct. 04, 2018 Management & Business Management & Business
RIKEN GENESIS to Perform Sequencing Analysis for Todai OncoPanel
-Supporting Launch of Advanced Medical Care “Cancer Gene Panel Testing” by the University of Tokyo-
Sep. 14, 2018 Management & Business Management & Business
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Third Consecutive Year
Sep. 14, 2018 Management & Business Management & Business
Announcement of Personnel Change (PDF:52KB)
Sep. 05, 2018 Products & Solution Products & Solution
Sysmex Launches New Product for the China Market in Its Automated Hematology Analyzer XS-Series
-Using a New Product Supply Scheme to Accelerate Business Expansion in China-
Aug. 30, 2018 Products & Solution Products & Solution
Sysmex, Toppan Printing, and RIKEN GENESIS Commence Launch of Fully Automated System (Research Use Only) to Detect Gene Mutations in Cancer Tissue
-Streamlining the Gene Testing Processes to Standardize the Testing-
Aug. 23, 2018 Products & Solution Products & Solution
Sysmex Partec’s CyFlow™ Counter System, a System to Test for CD4+ Lymphocytes, Receives WHO Prequalification
-Aiming to Help Improve the Quality of HIV Diagnosis and Treatment in Emerging Markets and Developing Countries-
Aug. 16, 2018 Products & Solution Products & Solution
Sysmex America Opens “Center for Learning,” Expanding Training Facilities for Customers in North America
-Enhancing Its Service and Support to Further Increase Customer Satisfaction-
Aug. 08, 2018 Products & Solution Products & Solution
Sysmex to Launch HISCL™ Presepsin Assay Kit for Sepsis Testing
-Contributes to early diagnosis of bacterial sepsis by promoting presepsin testing in conjunction with the HISCL™-Series-
Aug. 03, 2018 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2019 (PDF:626KB)
Aug. 03, 2018 Management & Business Management & Business
Sysmex and JVCKENWOOD Jointly Establish Company to Use Micro and Nano-Fabrication Technology to Develop and Manufacture IVD Biodevices
Jul. 10, 2018 Management & Business Management & Business
Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services
Jun. 27, 2018 Management & Business Management & Business
Our Views and Policy regarding Investment Unit Reduction (PDF:31KB)
Jun. 27, 2018 Research & Development Research & Development
Sysmex, the Foundation for Biomedical Research and Innovation at Kobe, and Kyoto University Begin Joint Research on Technologies for Diagnosing Immunological Diseases
May. 10, 2018 Products & Solution Products & Solution
Sysmex Launches New Products in Its System for the Testing of Cancer Lymph Node Metastasis Using the OSNA™ Method: Gene Amplification Detector RD-200 and LYNOAMP™ CK19
-Contributing to Standardization in the Testing of Cancer Lymph Node Metastasis by Shortening Testing Times and Augmenting Processing Capacity-
May. 09, 2018 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 (PDF:415KB)
May. 09, 2018 Investor Relations Investor Relations
Sysmex Announces Changes from Financial Forecasts and Year-End Dividend (Commemorative Dividend) for the Fiscal Year Ended March 31, 2018 (PDF:87KB)
May. 09, 2018 Investor Relations Investor Relations
Notice of the Booking of a Provision of Allowance for Doubtful Accounts (Non-Consolidated) Related to Loans to an Affiliated Company (PDF:40KB)
May. 09, 2018 Management & Business Management & Business
Sysmex Group Formulates New Long-Term Management Goals
Celebrating Our 50th Anniversary by Taking on New Challenges to Move to the Next Stage
May. 09, 2018 Management & Business Management & Business
Sysmex Announces “Sysmex Eco-Vision 2025”
—To contribute to a sustainable society—
May. 08, 2018 Management & Business Management & Business
Sysmex to Establish Bio-Diagnostic Reagent Center
Reinforcing Our Diagnostic Reagent Development and Production Function by Establishing a Location to Handle Integrated Development through Production and Distribution of Bio-Diagnostic Reagents
May. 01, 2018 Management & Business Management & Business
Sysmex Employee to Receive the “Medal with Purple Ribbon,” a Spring 2018 Medal of Honor
Apr. 26, 2018 Management & Business Management & Business
Sysmex to Launch JICA Project in the Republic of Ghana:
"Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology”
Apr. 24, 2018 Products & Solution Products & Solution
Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers
-Initiatives toward Further Standardization and Quality Improvement of Clinical Testing-
Apr. 05, 2018 Products & Solution Products & Solution
Sysmex Launches Caresphere,™ a New Network Solution
-Supporting the Intelligent Use of Information for the Healthcare of the Future, Where the Use of Information is Accelerating-
Apr. 04, 2018 Research & Development Research & Development
Sysmex and ImmuniT Research Enter Agreement on the Sublicensing of a Patent Related to a Diagnosing Method for Predicting Efficacy of Immune Checkpoint Inhibitors
Apr. 03, 2018 Research & Development Research & Development
Advanced Medical Care Approval Received for Multiplex Gene Panel Testing to Advancing Personalized Medicine
Apr. 02, 2018 Management & Business Management & Business
Sysmex Formulates New Corporate Message:“Lighting the way with diagnostics”
Mar. 29, 2018 Products & Solution Products & Solution
Sysmex to Launch the Automated High-sensitive Immunoassay System for Research Applications HI-1000
-Promoting R&D on New Biomarkers Aimed at Achieving Personalized Medicine through Liquid Biopsy-
Mar. 20, 2018 Management & Business Management & Business
Japan’s first-ever industry-academia alliance to realize the development of innovative medicine in Japan
Implementation of a one-stop bioresource project in Kyoto University, and the establishment of KBBM Co., Ltd. as a model of “industry-in-the-academia” industry-academia partnership
Mar. 09, 2018 Other Other
Sysmex to Be Special Sponsor of the Kobe Marathon 2018
-We are pleased to have sponsored this exciting event since its inception in 2011-
Mar. 08, 2018 Management & Business Management & Business
Announcement of Organizational and Personnel Changes (PDF:182KB)
Feb. 20, 2018 Other Other
Sysmex Celebrates Its 50th Anniversary of Establishment
-Gratitude for All the Support over the Past 50 Years and a Commitment to Continue Taking on Challenges toward the Advancement of Healthcare-
Feb. 19, 2018 Other Other
FY2017 Nakatani Award and Research Grant Recipients Announced (PDF:117KB)
Feb. 06, 2018 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2018 (PDF:347KB)
Jan. 22, 2018 Management & Business Management & Business
Sysmex Harmony Co., Ltd., Certified as Special Subsidiary Company
Back to "About Sysmex"